tldrdailynews.com logo

Eli Lilly's Oral Obesity Pill Shows Promise as an Effective Alternative to Injectable GLP-1s

1 min read
Source: wired.com
Eli Lilly's Oral Obesity Pill Shows Promise as an Effective Alternative to Injectable GLP-1s
Photo: wired.com
TL;DR

Eli Lilly's new oral obesity pill, orforglipron, shows comparable effectiveness to injectable GLP-1 drugs like Ozempic in weight loss and blood sugar reduction, with potential advantages in cost, convenience, and accessibility, and is seeking regulatory approval.

Topics:businesshealth#diabetes#eli-lilly#glp-1#health#obesity-pill#weight-loss
Share this article
  1. Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s  wired.com
  2. Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine  Eli Lilly
  3. Lilly expects orforglipron obesity results in third quarter  Reuters
  4. Lilly Obesity Pill to Rival Shots Holds Up to Scrutiny in Trial  Bloomberg.com
  5. Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal  CNBC

Want the full story? Read the original reporting

Read on wired.com